Bahng, H. H., Green, S., Lai, A., Hu, J., Green, R., Iwamoto, F., . . . Nghiemphu, P. (2017). ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro Oncol.
Citación estilo ChicagoBahng, Hye Hyun, Stacey Green, Albert Lai, Jethro Hu, Richard Green, Fabio Iwamoto, Andrew B. Lassman, Timothy Cloughesy, and Phioanh Nghiemphu. "ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2017.
Cita MLABahng, Hye Hyun, et al. "ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2017.